Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
<p>Abstract</p> <p>Since the mid-1990's a trickle of publications from scattered independent laboratories have presented data suggesting that the systemic amyloid precursor transthyretin (TTR) could interact with the amyloidogenic β-amyloid (Aβ) peptide of Alzheimer's dis...
Main Authors: | Li Xinyi, Buxbaum Joel N |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://www.molecularneurodegeneration.com/content/6/1/79 |
Similar Items
-
Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
by: Gabriela Molina O, et al.
Published: (2014-11-01) -
Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01) -
Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
by: Bokyung Kim, et al.
Published: (2021-03-01) -
Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
by: Carsten Tschöpe, et al.
Published: (2022-04-01) -
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?
by: Federica Saponaro, et al.
Published: (2020-11-01)